Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)

PHASE3CompletedINTERVENTIONAL

Enrollment

4,086

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Rheumatoid Arthritis

Interventions

DRUG

MK0663, etoricoxib

DRUG

Comparator: Diclofenac sodium

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00092742 - Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072) | Biotech Hunter | Biotech Hunter